Search
for
Sort by
Research 691–720 of 1000+
- News in brief
- Slow progress in prostate cancer
- The Breast Cancer Wars: Fear, Hope and the Pursuit of a Cure in Twentieth Century America
- National scientific medical meeting 1996 abstracts
- Classified Advertising
- Association between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Korean androgenetic alopecia
- NEW YORK DERMATOLOGICAL SOCIETY
- Hormesis and medicine
- The Rotterdam Study: 2016 objectives and design update
- Polycystic Ovary Syndrome
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Syphilis: A great imitator
- Dermoscopy: distinguishing malignant tumors from benign
- Diagnosis and treatments of hirsutism: where are we?
- Dermatology for the elderly: An Indian perspective
- Philosophy and technique in hair restoration surgery
- Aldesleukin
- Veterinary Pharmacology
- Dermatological drugs, topical agents, and cosmetics
- New Target for Minoxidil in the Treatment of Androgenetic Alopecia
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Evaluation of hair growth promoting activity of petroleum ether extract of Abrus precatorius Linn. on Wistar Albino rats
- EFFECT OF ECLIPTA ALBA ON SCOPOLAMINE INDUCED AMNESIA IN MICE
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report
- Niosomal and ethosomal gels: A comparative in vitro and ex vivo evaluation for repurposing of spironolactone
- Caractérisation physique et chimique des substances à activité thérapeutique : application aux études de profil de stabilité et de préformulation
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Skin Targeting of An Optimized Caffeine Nanostructured Lipid Carrier With Improved Efficiency Against Chemotherapy Induced Alopecia
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions